No Data
No Data
Huabang Health (002004.SZ) announced first-quarter results, net profit of 156 million yuan, a decrease of 12.18%
Huabang Health (002004.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 2,915 billion yuan, a year-on-year decrease of 2.02%. Net profit attributable to shareholders of listed companies was 156 million yuan, a year-on-year decrease of 12.18%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 149 million yuan, a year-on-year decrease of 11.79%.
Huabang Health (002004.SZ): The holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and new polymer materials
Gelonghui, March 13 | Huabang Health (002004.SZ) said on the investor interactive platform that the company's holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and novel polymer materials. The business covers inorganic chemicals, carboxyl chlorides, hydroxychlorides, and the novel polymer material polyether ketone. The main products include inorganic chemicals (including sulfoxide chloride and sulfuryl chloride), carboxyl chloride (including aramid polymer monomers, para-nitrobenzoyl chloride, chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxy chlorides (including chloroacetyl chloride, etc.), and polychlorochlorides (including polychlorinated polymers) ether ketone ketone, etc.
Huabang Health (002004.SZ): Controlling shareholders pledge 4.3 million shares
Gelonghui, Feb. 7 | Huabang Health (002004.SZ) announced that the company recently received a notice from Xizang Huibang Technology Co., Ltd. (“Huibang Technology”), the holding stock of the company, and learned that it will pledge some of the company's shares. The number of shares pledged this time is 4.3 million shares.
Express News | More than 10 listed companies announced additional shareholders' pledges after the market, 20 companies interacted easily to respond to whether there is a risk of stock pledges
Huabang Health (002004.SZ): A total cost of 15.27 million yuan to buy back 3.355,800 shares
Gelonghui, Feb. 1 | Huabang Health (002004.SZ) announced that as of January 31, 2024, the company had repurchased a total of 33558.08 million shares through centralized trading, accounting for 0.17% of the company's current total share capital. The highest transaction price was 4.65 yuan/share, the lowest transaction price was 4.23 yuan/share, and the total amount paid was 15.027 million yuan (not including transaction fees).
Huabang Health (002004.SZ): As of the end of the third quarter of 2023, the company's travel sector revenue exceeded 900 million yuan
Gelonghui, January 17 | Huabang Health (002004.SZ) said on the investor interactive platform that the company's tourism resources are widely distributed in various 5A scenic spots in Yunnan, Shaanxi, Chongqing, Guangxi, etc., and its business covers scenic ropeway transportation, hotel management, tourism and entertainment. By the end of the third quarter of 2023, the company's travel sector had revenue of over 900 million yuan.
No Data